NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
NMD Pharma is a clinical-stage biotech company that delivers life-transforming therapies for people living with neuromuscular diseases. They use ClC-1 Cl- ion channel inhibitors to treat neuromuscular diseases. Their translational muscle electrophysiology platform leverages in-depth knowledge of muscle physiology and muscular disorders to identify and develop first-class therapeutics for neuromuscular diseases that are unmet medically.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 15, 2022 | Series Unknown | €35M | 1 | — | — | Detail |
Mar 23, 2018 | Series A | €38M | 1 | — | — | Detail |
Jul 1, 2016 | Series Unknown | €2.70M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lundbeckfonden Emerge | — | Series Unknown |